Molecular and metabolic imaging of atherosclerosis.

Atherosclerosis is a systemic disease that affects most major arteries of the body and is the most common cause of premature death in the western world. It develops slowly and often asymptomatically, so that for many patients its first manifestation is sudden cardiac death, stroke, or myocardial infarction. The current gold standard for imaging atherosclerosis is x-ray angiography. However, recent advances in understanding of the pathobiology of atherosclerosis have highlighted the inadequacies of this technique and the need for better imaging approaches. The purpose of this article is to briefly outline the biology of atherosclerosis and to review the techniques available to image it, concentrating specifically on those that detect metabolic or inflammatory changes within the atherosclerotic plaque.

[1]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[2]  R. Taillefer,et al.  Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis. , 2003, Archives of internal medicine.

[3]  P. Ganz,et al.  Endothelial function. From vascular biology to clinical applications. , 2002, The American journal of cardiology.

[4]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[5]  G. D. De Meyer,et al.  In Vivo Temperature Heterogeneity of Atherosclerotic Plaques Is Determined by Plaque Composition , 2002, Circulation.

[6]  René M. Botnar,et al.  Coronary magnetic resonance angiography for the detection of coronary stenoses. , 2001, The New England journal of medicine.

[7]  R. Wahl,et al.  Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) , 2001, Nuclear medicine communications.

[8]  Werner Moshage,et al.  Detection of Coronary Artery Stenoses by Contrast-Enhanced, Retrospectively Electrocardiographically-Gated, Multislice Spiral Computed Tomography , 2001, Circulation.

[9]  A. Alavi,et al.  F-18 FDG Uptake in the Large Arteries: A New Observation , 2001, Clinical nuclear medicine.

[10]  D. Waters,et al.  Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: A canine model. , 2000, Circulation.

[11]  P Toutouzas,et al.  Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. , 1999, Circulation.

[12]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[13]  Ignasi Carrió,et al.  Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  M. Bennett,et al.  Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. , 1998, Circulation research.

[15]  M. Bennett,et al.  Thrombin generation by apoptotic vascular smooth muscle cells. , 1997, Blood.

[16]  M J Davies,et al.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.

[17]  G. Ronga,et al.  Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. , 1996, Atherosclerosis.

[18]  V. Fuster,et al.  Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.

[19]  V. Fuster,et al.  Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. , 1996, Circulation.

[20]  G Baumann,et al.  Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. , 1996, Journal of the American College of Cardiology.

[21]  W. Vaughn,et al.  Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients. , 1996, Journal of the American College of Cardiology.

[22]  L. Knight,et al.  Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  C J Slager,et al.  Volumetric intracoronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis? , 1995, Atherosclerosis.

[24]  N. Oku,et al.  Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  M. Cerqueira,et al.  Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. , 1995, Circulation.

[26]  M J Davies,et al.  Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention. , 1995, European heart journal.

[27]  J. Rumberger,et al.  Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. , 1995, Circulation.

[28]  V. Fuster,et al.  T2-weighted contrast for NMR characterization of human atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[29]  A. Fox,et al.  Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. , 1995, Stroke.

[30]  R. Edelman,et al.  Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? , 1995, Stroke.

[31]  Y. Uchida,et al.  Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. , 1995, American heart journal.

[32]  K. Spicer,et al.  Biodistribution and radioimmunopharmacokinetics of 131I-Ama monoclonal antibody in atherosclerotic rabbits. , 1995, Nuclear medicine and biology.

[33]  V. Torchilin,et al.  Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. , 1995, Circulation.

[34]  P. Libby Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[35]  M. G. Walker,et al.  Indium‐111 platelet scintigraphy in vascular disease , 1995, The British journal of surgery.

[36]  J. Seabold,et al.  Will a radiolabeled antibody replace indium-111-platelets to detect active thrombus? , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  M. Cerqueira,et al.  Imaging arterial thrombosis: comparison of technetium-99m-labeled monoclonal antifibrin antibodies and indium-111-platelets. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  A. Maseri,et al.  Vasoreactivity of the Culprit Lesion in Unstable Angina , 1994, Circulation.

[39]  P. Serruys,et al.  The 'Ermenonville' classification of observations at coronary angioscopy--evaluation of intra- and inter-observer agreement. European Working Group on Coronary Angioscopy. , 1994, European heart journal.

[40]  H Sinzinger,et al.  Evidence for Lipid Regression in Humans In Vivo Performed by 123Iodine‐Low‐Density Lipoprotein Scintiscanning , 1994, Annals of the New York Academy of Sciences.

[41]  I. Ferrer,et al.  Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury , 1993, European Journal of Nuclear Medicine.

[42]  R. Lees,et al.  External Imaging of Atherosclerosis in Rabbits Using an 123I‐Labeled Synthetic Peptide Fragment , 1993, Journal of clinical pharmacology.

[43]  P. Demacker,et al.  Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  L. Knight Scintigraphic methods for detecting vascular thrombus. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  R. Lees,et al.  Time course of 125I-labeled LDL accumulation in the healing, balloon-deendothelialized rabbit aorta. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[46]  J. Salonen,et al.  Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[47]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  J. Tait,et al.  Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. , 1990, The Journal of biological chemistry.

[49]  M J Davies,et al.  A macro and micro view of coronary vascular insult in ischemic heart disease. , 1990, Circulation.

[50]  P. Alderson,et al.  Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  U. Steinbrecher,et al.  Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. , 1989, The Journal of biological chemistry.

[52]  V. Fuster,et al.  Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. , 1988, Journal of the American College of Cardiology.

[53]  A. Fischman,et al.  Imaging Human Atherosclerosis with 99mTc‐labeled Low Density Lipoproteins , 1988, Arteriosclerosis.

[54]  V. Fuster,et al.  Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  R. Anholt,et al.  The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. , 1986, The Journal of biological chemistry.

[56]  E. Hoffman,et al.  Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  K. Ericson,et al.  DETECTION OF ATHEROSCLEROTIC PLAQUES IN CAROTID ARTERIES BY THE USE OF 123I-FIBRINOGEN , 1978, The Lancet.

[58]  W. Edwards Blood Vessels , 1959 .

[59]  P. Angelberger,et al.  Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage , 2004, European Journal of Nuclear Medicine.

[60]  A. Alavi,et al.  18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. , 2002, Seminars in nuclear medicine.

[61]  P Toutouzas,et al.  Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. , 2000, Journal of molecular and cellular cardiology.

[62]  J. Witztum,et al.  Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[63]  R. Lees,et al.  Radiopharmaceutical Imaging of Atherosclerosis , 1996 .

[64]  V. Fuster Syndromes of atherosclerosis : correlations of clinical imaging and pathology , 1996 .

[65]  T. Ido,et al.  Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  T. Lüscher,et al.  Endothelial dysfunction in coronary artery disease. , 1993, Annual review of medicine.

[67]  T. Lüscher,et al.  Endothelium-dependent contractions. , 1991, Blood vessels.

[68]  R. Ahmadi,et al.  Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. , 1989, Stroke.

[69]  T. Carew,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[70]  R. Ross,et al.  Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. , 1984, The American journal of pathology.

[71]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.